Frederick C. Pearson

824 total citations
34 papers, 633 citations indexed

About

Frederick C. Pearson is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Dermatology. According to data from OpenAlex, Frederick C. Pearson has authored 34 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Dermatology. Recurrent topics in Frederick C. Pearson's work include Immune Response and Inflammation (10 papers), Occupational exposure and asthma (6 papers) and Contact Dermatitis and Allergies (6 papers). Frederick C. Pearson is often cited by papers focused on Immune Response and Inflammation (10 papers), Occupational exposure and asthma (6 papers) and Contact Dermatitis and Allergies (6 papers). Frederick C. Pearson collaborates with scholars based in United States, Canada and Germany. Frederick C. Pearson's co-authors include E. Ribi, Jerry Dolovich, Jason F. Wiggins, Arthur G. Johnson, C R Raetz, N Qureshi, J. E. Peterson, Koichi Takayama, John L. Cantrell and Ralph J. Caruana and has published in prestigious journals such as New England Journal of Medicine, Nature Biotechnology and Applied and Environmental Microbiology.

In The Last Decade

Frederick C. Pearson

32 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick C. Pearson United States 15 208 131 93 73 65 34 633
J. Gordon Canada 14 368 1.8× 140 1.1× 102 1.1× 54 0.7× 105 1.6× 28 841
Susanne Loeliger Switzerland 7 368 1.8× 127 1.0× 74 0.8× 26 0.4× 47 0.7× 10 724
Carl W. Oettinger United States 18 263 1.3× 197 1.5× 76 0.8× 39 0.5× 81 1.2× 48 911
John Savill United Kingdom 15 98 0.5× 239 1.8× 66 0.7× 64 0.9× 78 1.2× 27 706
Bernard Halpern United States 12 94 0.5× 53 0.4× 51 0.5× 206 2.8× 64 1.0× 31 604
Richard T. Sawyer United States 23 389 1.9× 222 1.7× 255 2.7× 89 1.2× 57 0.9× 48 1.4k
W. F. Willoughby United States 12 267 1.3× 123 0.9× 82 0.9× 36 0.5× 62 1.0× 28 626
Y Aron France 17 79 0.4× 337 2.6× 80 0.9× 86 1.2× 37 0.6× 31 841
Helen J. Wright United Kingdom 15 476 2.3× 336 2.6× 59 0.6× 123 1.7× 33 0.5× 20 1.1k
Necmettın Akdeniz Türkiye 16 140 0.7× 171 1.3× 115 1.2× 37 0.5× 66 1.0× 109 923

Countries citing papers authored by Frederick C. Pearson

Since Specialization
Citations

This map shows the geographic impact of Frederick C. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick C. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick C. Pearson more than expected).

Fields of papers citing papers by Frederick C. Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick C. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick C. Pearson. The network helps show where Frederick C. Pearson may publish in the future.

Co-authorship network of co-authors of Frederick C. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick C. Pearson. A scholar is included among the top collaborators of Frederick C. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick C. Pearson. Frederick C. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deng, April, et al.. (2006). Perinuclear Antineutrophil Cytoplasmic Antibody‐Associated Vasculitis in a Patient With Graves' Disease Treated With Methimazole. SKINmed Dermatology for the Clinician. 5(6). 302–305. 7 indexed citations
3.
Sidwell, Robert W., Donald F. Smee, Reed P. Warren, et al.. (1993). Murine cytomegalovirus-inhibitory effects of ImuVert. Antiviral Research. 20(4). 279–292. 5 indexed citations
4.
Jiménez, Joaquín J., et al.. (1992). Protection from Chemotherapy-Induced Neutropenia by ImuVert. The American Journal of the Medical Sciences. 303(2). 83–85. 4 indexed citations
5.
Ogilvie, Gregory K., et al.. (1992). Use of a biological extract of Serratia marcescens to decrease doxorubicin-induced myelosuppression in dogs. American Journal of Veterinary Research. 53(10). 1787–1790. 2 indexed citations
6.
Weisenthal, Larry M., Patricia L. Dill, & Frederick C. Pearson. (1991). Effect of Prior Cancer Chemotherapy on Human Tumor-Specific Cytotoxicity In Vitro in Response to Immunopotentiating Biologic Response Modifiers. JNCI Journal of the National Cancer Institute. 83(1). 37–42. 14 indexed citations
7.
Ogilvie, G K, et al.. (1991). Evaluation of a biologic response modifier derived from Serratia marcescens: effects on feline macrophages and usefulness for the prevention and treatment of viremia in feline leukemia virus-infected cats.. PubMed. 3(4). 231–8. 3 indexed citations
8.
Cunningham‐Rundles, S. & Frederick C. Pearson. (1990). Imu Vert activation of natural killer cytotoxicity and interferon gamma production via CD16 triggering. International Journal of Immunopharmacology. 12(6). 589–598. 6 indexed citations
9.
House, Robert V., Frederick C. Pearson, & Peter Thomas. (1990). Selective potentiation of host resistance in mice following treatment with Pyrexol.. PubMed. 2(3). 175–8. 3 indexed citations
10.
McCall, Catherine, et al.. (1989). Biotherapy: A New Dimension in Cancer Treatment. Nature Biotechnology. 7(3). 231–240. 7 indexed citations
11.
Pearson, Frederick C., et al.. (1988). Determination of Endotoxin Levels and Their Impact on Interleukin-1 Generation in Continuous Ambulatory Peritoneal Dialysis and Hemodialysis. Blood Purification. 6(3). 207–212. 7 indexed citations
12.
Pearson, Frederick C., et al.. (1987). Ethylene Oxide Sensitivity in Hemodialysis Patients. Artificial Organs. 11(2). 100–103. 18 indexed citations
13.
Pearson, Frederick C., et al.. (1987). Effect of nonsterility on the activity of Limulus amebocyte lysate.. PubMed. 36(5). 196–8.
14.
Leitman, Susan F., Howard Boltansky, Harvey J. Alter, Frederick C. Pearson, & Michael Kaliner. (1986). Allergic Reactions in Healthy Platelet-Pheresis Donors Caused by Sensitization to Ethylene Oxide Gas. New England Journal of Medicine. 315(19). 1192–1196. 33 indexed citations
15.
Holmes, C. J., et al.. (1986). Effect of monophosphoryl lipid A on host resistance to bacterial infection. Infection and Immunity. 53(3). 711–712. 39 indexed citations
16.
Caruana, Ralph J., Robert W. Hamilton, & Frederick C. Pearson. (1985). Dialyzer Hypersensitivity Syndrome: Possible Role of Allergy to Ethylene Oxide. American Journal of Nephrology. 5(4). 271–274. 22 indexed citations
17.
Pearson, Frederick C., et al.. (1985). Comparison of several control standard endotoxins to the National Reference Standard Endotoxin--an HIMA collaborative study. Applied and Environmental Microbiology. 50(1). 91–93. 19 indexed citations
18.
Dolovich, Jerry, et al.. (1984). Allergy to Ethylene Oxide in Chronic Hemodialysis Patients. Artificial Organs. 8(3). 334–337. 48 indexed citations
19.
Pearson, Frederick C., et al.. (1984). Comparison of Chemical Analyses of Hollow‐Fiber Dialyzer Extracts. Artificial Organs. 8(3). 291–298. 44 indexed citations
20.
Takayama, Koichi, N Qureshi, C R Raetz, et al.. (1984). Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infection and Immunity. 45(2). 350–355. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Gordon Breakdown of academic impact, for papers by Susanne Loeliger Breakdown of academic impact, for papers by Carl W. Oettinger Breakdown of academic impact, for papers by John Savill Breakdown of academic impact, for papers by Bernard Halpern Breakdown of academic impact, for papers by Richard T. Sawyer Breakdown of academic impact, for papers by W. F. Willoughby Breakdown of academic impact, for papers by Y Aron Breakdown of academic impact, for papers by Helen J. Wright Breakdown of academic impact, for papers by Necmettın Akdeniz
Rankless by CCL
2026